-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Gain Therapeutics, Inc. quarterly and annual Revenues history and change rate from Q1 2020 to 2023.
- Gain Therapeutics, Inc. Revenues for the quarter ending 31 Mar 2023 was $55,180, a 23% increase year-over-year.
- Gain Therapeutics, Inc. annual Revenues for 2023 was $55,180, a 61% decline from 2022.
- Gain Therapeutics, Inc. annual Revenues for 2022 was $140,108, a 15% decline from 2021.
- Gain Therapeutics, Inc. annual Revenues for 2021 was $164,994, a 471% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)